U.S. Healthtech Stock News

Flowserve Corporation has reported past first-quarter 2026 results, with sales of US$1,068.27 million versus US$1,144.54 million a year earlier, while net income rose to US$81.68 million and diluted EPS from continuing operations increased to US$0.64 from US$0.56. Despite the year-on-year sales decline and a miss versus analyst revenue expectations, Flowserve delivered EPS above forecasts and reaffirmed its full-year adjusted EPS guidance, highlighting management’s focus on profitability and...

NVIDIA (NVDA) is back in the spotlight after its market cap and share price hit fresh records, then faced a sharp swing in sentiment as worries about AI spending followed reports of OpenAI missing internal growth targets. See our latest analysis for NVIDIA. NVIDIA’s recent pullback, including a 1-day share price decline of 1.84% to US$209.25, comes after a strong run where its 30-day share price return of 19.98% and 1-year total shareholder return of 87.53% highlight momentum that has...

Essex Property Trust (ESS) opened 2026 with Q1 funds from operations of US$278.0 million, setting the tone for how investors will read the latest results against a year of shifting profitability and margins. Over the past few quarters, total revenue has moved from US$472.7 million in Q4 2024 to US$487.7 million in Q4 2025, while basic EPS shifted between US$4.01 and US$1.25 across that period. This gives a clearer view of how earnings power has tracked the top line. With net profit margin...

Modine Manufacturing recently appointed Art Laszlo as president of its newly created data centers segment, formalizing a push into data center cooling after investing more than US$100 million in added capacity, including a new Franklin, Wisconsin plant. This move follows data center cooling revenues rising to about US$640 million in fiscal 2025 and the decision to spin off the weaker-performing Performance Technologies segment into a combination with Gentherm Incorporated, sharpening...

What recent returns suggest about TriMas stock TriMas (TRS) has delivered a 50% total return over the past year and 46% over the past 3 months, while year to date performance is slightly negative, giving investors a mixed recent picture. Over the past month, the stock is roughly flat, and the past week and single day moves have been mildly negative, which may interest investors comparing these shorter term swings with the stronger 1 year performance. See our latest analysis for TriMas. At a...

It looks like 1st Source Corporation ( NASDAQ:SRCE ) is about to go ex-dividend in the next 4 days. The ex-dividend...

Those following along with Charter Communications, Inc. ( NASDAQ:CHTR ) will no doubt be intrigued by the recent...

Janux Therapeutics, Inc. ( NASDAQ:JANX ) shareholders may have reason to be concerned, as several insiders sold their...

While Globavend Holdings Limited ( NASDAQ:GVH ) might not have the largest market cap around , it received a lot of...

Despite a 15% gain in ClearOne, Inc.'s ( NASDAQ:CLRO ) stock price this week, shareholders shouldn't let up. The fact...

GE HealthCare Technologies' Q1 Update Sets the Stage for the Next Leg of the Story GE HealthCare Technologies (GEHC) has kicked off 2026 with Q1 results that sit on top of a solid recent run, with Q4 2025 revenue at US$5.7 billion and basic EPS of US$1.29, backed by net income of US$589 million. Over the past few quarters, the company has seen revenue move from US$5.3 billion in Q4 2024 to US$5.7 billion in Q4 2025, while basic EPS across 2025 ranged between roughly US$0.98 and US$1.29,...

Investors may be wondering whether Entergy at around US$114.67 still offers value, or if most of the easy gains are already on the table. The share price sits at US$114.67, with returns of 3.8% over 7 days, 3.3% over 30 days, 22.2% year to date and 41.7% over 1 year. The 3 year and 5 year returns stand at 140.6% and 154.8% respectively. Recent price action sits against a backdrop of ongoing investor interest in regulated utilities as income and stability plays, with Entergy often part of...

In recent days, BellRing Brands has been caught up in unusual swings across the consumer staples sector, where stocks such as Grocery Outlet have seen volatility that challenges the group’s reputation for stability. This sector-wide turbulence matters because it suggests broader market forces, rather than company‑specific developments, are increasingly influencing how investors view BellRing’s defensive qualities. Against this backdrop of sector-wide volatility reshaping perceptions of...

Nebius Group stock: event driven snapshot Nebius Group (NBIS) has come onto investors’ radar after its recent rebranding from Yandex N.V. to Nebius Group N.V., shifting the listed entity’s focus toward full stack AI infrastructure and related platforms. See our latest analysis for Nebius Group. The share price has been volatile around the rebrand, with a 1 day share price return of 4.19% at a last close of $141.19, following a 30 day share price return of 53.03% and a very large 1 year total...

Whilst it may not be a huge deal, we thought it was good to see that the Investar Holding Corporation ( NASDAQ:ISTR...

Core & Main (CNM) has drawn investor attention after recent share price moves, with the stock closing at US$48.44. That puts its market value near US$9.6b, supported by US$7,647m in revenue and US$441m in net income. See our latest analysis for Core & Main. Recent trading has been subdued, with a 1 day share price decline of 2.16% and a 7 day share price decline of 1.06%, while the 3 year total shareholder return of 80.28% points to stronger longer term momentum. If Core & Main has you...

SentinelOne (S) shares are in focus after the company announced a new partnership with identity security provider Silverfort, aimed at securing human and non human identities across endpoints, cloud workloads, and AI applications. See our latest analysis for SentinelOne. Recent share price momentum has picked up, with a 16.57% 1 month share price return and a 4.48% 3 month share price return taking SentinelOne to US$14.70. However, the 1 year total shareholder return of a 20.54% decline shows...

Why Polaris stock is back in focus after Q1 2026 earnings Polaris (PII) is on investors’ radar after reporting Q1 2026 results that topped revenue and EPS expectations, expanded gross margins despite tariff pressure, and kept full year guidance intact. See our latest analysis for Polaris. The earnings beat has been followed by a sharp shift in sentiment, with a 25.86% 1 month share price return and 108.20% 1 year total shareholder return contrasting with weaker 3 and 5 year total shareholder...

If you are wondering whether Samsara's current share price reflects its true worth, this breakdown will help you connect the recent share moves with the underlying valuation. The stock closed at US$29.37, with returns of an 8.3% decline over 7 days, a 4.1% decline over 30 days, a 13.4% decline year to date and a 25.9% decline over 1 year, while still sitting on a 73.9% gain over 3 years. Recent headlines around Samsara have focused on its role in software for connected operations and how...

Recent share performance and business context With no single headline event driving Rhythm Pharmaceuticals (RYTM) today, the stock’s recent moves and fundamentals are in focus as investors weigh share price performance against the company’s rare disease portfolio. See our latest analysis for Rhythm Pharmaceuticals. The recent 1 day share price return of a 2.45% decline and 90 day share price return of a 19.9% decline contrast with a 1 year total shareholder return of 28.71% and a very large 3...

Wondering whether Brown-Forman's share price now reflects a fair deal or an overreaction, especially after a long slide? This article focuses squarely on what you are getting for the price you pay. The stock last closed at US$24.87, with returns of a 12.8% decline over 7 days, 6.9% decline over 30 days, 4.9% decline year to date, 26.2% decline over 1 year, 58.6% decline over 3 years and 63.7% decline over 5 years. This naturally raises questions about how the current valuation stacks...

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by an impressive 28%, with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying small-cap stocks that are perceived as undervalued and exhibit insider activity can provide intriguing opportunities for investors seeking to capitalize on potential growth.

Preformed Line Products Company recently reported its first-quarter 2026 results, with sales rising to US$176.28 million from US$148.54 million a year earlier, while net income eased to US$10.52 million and diluted earnings per share from continuing operations slipped to US$2.14. This combination of stronger top-line performance but slightly weaker profitability highlights shifting cost or margin pressures that may be reshaping the company’s financial profile. We’ll now examine how this...

Over the last 7 days, the United States market has remained flat, yet it has shown a significant rise of 28% over the past year with earnings forecasted to grow by 16% annually. In this context, identifying high growth tech stocks becomes crucial as they have the potential to capitalize on these favorable conditions and contribute positively to an investment portfolio.